{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:15:15Z","timestamp":1793330115537,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["23DZ2291500"],"award-info":[{"award-number":["23DZ2291500"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171179"],"award-info":[{"award-number":["82171179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371213"],"award-info":[{"award-number":["82371213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114442","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:34:12Z","timestamp":1742376852000},"page":"114442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Farrerol alleviates cognitive impairments in chronic cerebral hypoperfusion via suppressing NLRP3 inflammasome-mediated pyroptosis"],"prefix":"10.1016","volume":"153","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2025.114442_bb0005","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/ATVBAHA.119.311908","article-title":"Epidemiology of vascular dementia","volume":"39","author":"Wolters","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114442_bb0010","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.7150\/thno.68304","article-title":"Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment","volume":"12","author":"Rajeev","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.intimp.2025.114442_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-021-00506-8","article-title":"The role of inflammasomes in vascular cognitive impairment","volume":"17","author":"Poh","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.intimp.2025.114442_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: Gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.intimp.2025.114442_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1073511","article-title":"What type of cell death occurs in chronic cerebral hypoperfusion? A review focusing on pyroptosis and its potential therapeutic implications","volume":"17","author":"He","year":"2023","journal-title":"Front. Cell. Neurosci."},{"issue":"11","key":"10.1016\/j.intimp.2025.114442_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13137","article-title":"Pyroptosis: a promising therapeutic target for noninfectious diseases","volume":"54","author":"Li","year":"2021","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.intimp.2025.114442_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.26158","article-title":"Targeting inflammasomes to treat neurological diseases","volume":"90","author":"L\u00fcnemann","year":"2021","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114442_bb0040","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.114442_bb0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41419-023-05634-1","article-title":"Pyroptosis and degenerative diseases of the elderly","volume":"14","author":"Zhou","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.114442_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12974-020-01751-2","article-title":"Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-\u03baB signaling pathway and pyroptosis after secondary spinal cord injury","volume":"17","author":"Liu","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.intimp.2025.114442_bb0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12974-019-1688-9","article-title":"TREM-2-p38 MAPK signaling regulates neuroinflammation during chronic cerebral hypoperfusion combined with diabetes mellitus","volume":"17","author":"Zhang","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.intimp.2025.114442_bb0060","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5314","article-title":"Inflammatory signaling pathways in the treatment of Alzheimer\u2019s disease with inhibitors, natural products and metabolites (review)","volume":"52","author":"Zheng","year":"2023","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.114442_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13880209.2021.2006723","article-title":"The pharmacological properties and corresponding mechanisms of farrerol: a comprehensive review","volume":"60","author":"Qin","year":"2022","journal-title":"Pharm. Biol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.114442_bb0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11010-020-03878-5","article-title":"Farrerol maintains the contractile phenotype of VSMCs via inactivating the extracellular signal-regulated protein kinase 1\/2 and p38 mitogen-activated protein kinase signaling","volume":"475","author":"Liu","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.intimp.2025.114442_bb0075","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1007\/s12035-024-04031-9","article-title":"Farrerol alleviates cerebral ischemia-reperfusion injury by promoting neuronal survival and reducing Neuroinflammation","volume":"61","author":"Zhao","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2025.114442_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105739","article-title":"Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson\u2019s disease by suppressing the activation of the AKT and NF-\u03baB signaling pathways","volume":"75","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114442_bb0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.biopha.2018.10.053","article-title":"Farrerol attenuates \u03b2-amyloid-induced oxidative stress and inflammation through Nrf2\/Keap1 pathway in a microglia cell line","volume":"109","author":"Cui","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2025.114442_bb0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12974-021-02250-8","article-title":"NAD(+) improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1\/PGC-1\u03b1 pathway","volume":"18","author":"Zhao","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2025.114442_bb0095","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ijbiomac.2022.11.291","article-title":"Ameliorative effects of bromelain on aluminum-induced Alzheimer\u2019s disease in rats through modulation of TXNIP pathway","volume":"227","author":"Eraky","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2025.114442_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155883","article-title":"Pseudoginsenoside-F11 reduces cognitive impairment and white matter injury in vascular dementia by alleviating autophagy-lysosomal pathway deficiency","volume":"133","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"11","key":"10.1016\/j.intimp.2025.114442_bb0105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41419-023-06237-6","article-title":"ChemR23 activation attenuates cognitive impairment in chronic cerebral hypoperfusion by inhibiting NLRP3 inflammasome-induced neuronal pyroptosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.114442_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107422","article-title":"Curcumin protects against cognitive impairments in a rat model of chronic cerebral hypoperfusion combined with diabetes mellitus by suppressing neuroinflammation, apoptosis, and pyroptosis","volume":"93","author":"Zheng","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114442_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102010","article-title":"Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy","volume":"44","author":"Han","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2025.114442_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155578","article-title":"Aloe-emodin alleviates cerebral ischemia-reperfusion injury by regulating microglial polarization and pyroptosis through inhibition of NLRP3 inflammasome activation","volume":"129","author":"Li","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.intimp.2025.114442_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12974-023-02791-0","article-title":"The involvement of NLRP3 inflammasome in CUMS-induced AD-like pathological changes and related cognitive decline in mice","volume":"20","author":"Li","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"7661","key":"10.1016\/j.intimp.2025.114442_bb0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2025.114442_bb0135","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/CON.0000000000001124","article-title":"Vascular cognitive impairment and dementia","volume":"28","author":"Chang Wong","year":"2022","journal-title":"Continuum (Minneapolis, Minn.)"},{"issue":"1","key":"10.1016\/j.intimp.2025.114442_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-023-00640-5","article-title":"Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease","volume":"18","author":"Inoue","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.intimp.2025.114442_bb0145","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/ptr.6307","article-title":"Farrerol attenuates MPP(+) -induced inflammatory response by TLR4 signaling in a microglia cell line","volume":"33","author":"Cui","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2025.114442_bb0150","article-title":"The role of the effects of autophagy on NLRP3 Inflammasome in inflammatory nervous system diseases","volume":"9","author":"Zhao","year":"2021","journal-title":"Front. Cell Devel. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114442_bb0155","first-page":"4363","article-title":"Probucol protects against brain damage caused by intra-neural pyroptosis in rats with vascular dementia through inhibition of the Syk\/Ros pathway","volume":"16","author":"Zhu","year":"2024","journal-title":"Aging"},{"key":"10.1016\/j.intimp.2025.114442_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108756","article-title":"Network pharmacology-based strategy to investigate pharmacological mechanisms of Andrographolide for treatment of vascular cognitive impairment","volume":"108","author":"Zhao","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114442_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072037","article-title":"Farrerol ameliorates TNBS-induced colonic inflammation by inhibiting ERK1\/2, JNK1\/2, and NF-\u03baB signaling pathway","volume":"19","author":"Ran","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:48:52Z","timestamp":1762552132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925004321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"alternative-id":["S1567576925004321"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114442","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farrerol alleviates cognitive impairments in chronic cerebral hypoperfusion via suppressing NLRP3 inflammasome-mediated pyroptosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114442"}}